Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma

Introduction While immune checkpoint inhibitors represent the mainstream treatment for metastatic renal cell carcinoma, a standardized approach following immune checkpoint inhibitors remains unclear. We report a case of metastatic renal cell carcinoma treated with nivolumab rechallenge. Case present...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-07-01
Edice:	IJU Case Reports
Témata:	clear cell renal cell carcinoma immune checkpoint inhibitors nivolumab nivolumab rechallenge
On-line přístup:	https://doi.org/10.1002/iju5.12727
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!